Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Research and Development Expenses 2010-2023 | MKGAF

Merck annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Merck research and development expenses for the quarter ending December 31, 2023 were $0.719B, a 0.76% increase year-over-year.
  • Merck research and development expenses for the twelve months ending December 31, 2023 were $2.646B, a 0.37% decline year-over-year.
  • Merck annual research and development expenses for 2023 were $2.646B, a 0.37% decline from 2022.
  • Merck annual research and development expenses for 2022 were $2.656B, a 6.77% decline from 2021.
  • Merck annual research and development expenses for 2021 were $2.849B, a 9% increase from 2020.
  
Merck Annual Research and Development Expenses
(Millions of US $)
2023 $2,646
2022 $2,656
2021 $2,849
2020 $2,614
2019 $2,540
2018 $2,628
2017 $2,419
2016 $2,187
2015 $1,897
2014 $2,265
2013 $1,998
2012 $1,944
2011 $2,113
2010 $
2009 $
Merck Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31 $719
2023-09-30 $632
2023-06-30 $654
2023-03-31 $641
2022-12-31 $713
2022-09-30 $647
2022-06-30 $639
2022-03-31 $658
2021-12-31 $674
2021-09-30 $778
2021-06-30 $705
2021-03-31 $692
2020-12-31 $782
2020-09-30 $621
2020-06-30 $573
2020-03-31 $639
2019-12-31 $699
2019-09-30 $620
2019-06-30 $622
2019-03-31 $599
2018-12-31 $724
2018-09-30 $630
2018-06-30 $642
2018-03-31 $632
2017-12-31 $678
2017-09-30 $641
2017-06-30 $573
2017-03-31 $528
2016-12-31 $591
2016-09-30 $494
2016-06-30 $561
2016-03-31 $539
2015-12-31 $430
2015-09-30 $464
2015-06-30 $504
2015-03-31 $498
2014-12-31 $536
2014-09-30 $668
2014-06-30 $541
2014-03-31 $519
2013-12-31 $471
2013-09-30 $502
2013-06-30 $488
2013-03-31 $537
2012-12-31
2012-09-30 $464
2012-06-30 $519
2012-03-31
2011-12-31
2011-09-30
2011-06-30 $531
2011-03-31
2010-12-31
2010-09-30 $450
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.917B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.491B 29.79
Chugai Pharmaceutical (CHGCY) Japan $52.212B 23.34
Takeda Pharmaceutical (TAK) Japan $41.744B 6.76
Astellas Pharma (ALPMY) Japan $17.554B 27.71
Sandoz Group AG (SDZNY) Switzerland $14.632B 0.00
Neurocrine Biosciences (NBIX) United States $14.232B 39.40
Shionogi (SGIOY) Japan $13.760B 12.34
United Therapeutics (UTHR) United States $11.320B 12.06
Catalent (CTLT) United States $10.135B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.741B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.954B 7.64
Revolution Medicines (RVMD) United States $6.619B 0.00
Ionis Pharmaceuticals (IONS) United States $6.269B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.482B 0.00
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.547B 0.00
Summit Therapeutics (SMMT) United States $3.299B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.871B 0.00
PTC Therapeutics (PTCT) United States $2.620B 0.00
Corcept Therapeutics (CORT) United States $2.486B 22.53
Indivior (INDV) United States $2.431B 11.52
Dyne Therapeutics (DYN) United States $2.226B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.961B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.957B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.879B 11.13
Evotec AG (EVO) Germany $1.860B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.794B 18.54
Avadel Pharmaceuticals (AVDL) Ireland $1.658B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.593B 27.89
Soleno Therapeutics (SLNO) United States $1.588B 0.00
Ardelyx (ARDX) United States $1.547B 0.00
Xencor (XNCR) United States $1.475B 0.00
4D Molecular Therapeutics (FDMT) United States $1.299B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.287B 12.09
Pacira BioSciences (PCRX) United States $1.254B 12.48
Collegium Pharmaceutical (COLL) United States $1.236B 7.60
Cronos Group (CRON) Canada $1.035B 0.00
Cassava Sciences (SAVA) United States $0.957B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.951B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.943B 0.00
ARS Pharmaceuticals (SPRY) United States $0.904B 0.00
Relay Therapeutics (RLAY) United States $0.881B 0.00
USANA Health Sciences (USNA) United States $0.876B 14.19
Enliven Therapeutics (ELVN) United States $0.851B 0.00
Sage Therapeutics (SAGE) United States $0.799B 0.00
Ocular Therapeutix (OCUL) United States $0.777B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.744B 0.00
Savara (SVRA) United States $0.684B 0.00
Siga Technologies (SIGA) United States $0.663B 9.81
Silence Therapeutics (SLN) United Kingdom $0.641B 0.00
Exscientia (EXAI) United Kingdom $0.621B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.594B 0.00
Lyell Immunopharma (LYEL) United States $0.594B 0.00
OmniAb (OABI) United States $0.534B 0.00
KalVista Pharmaceuticals (KALV) United States $0.514B 0.00
Verve Therapeutics (VERV) United States $0.504B 0.00
Altimmune (ALT) United States $0.501B 0.00
ProKidney (PROK) United States $0.495B 0.00
Korro Bio (KRRO) United States $0.489B 0.00
Larimar Therapeutics (LRMR) United States $0.469B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.429B 0.00
Lexeo Therapeutics (LXEO) United States $0.405B 0.00
Tourmaline Bio (TRML) United States $0.403B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.391B 0.00
Esperion Therapeutics (ESPR) United States $0.386B 0.00
Harrow (HROW) United States $0.369B 0.00
Nature's Sunshine Products (NATR) United States $0.363B 20.33
Heron Therapeutics (HRTX) United States $0.352B 0.00
Organogenesis (ORGO) United States $0.331B 62.75
Fractyl Health (GUTS) United States $0.321B 0.00
Lyra Therapeutics (LYRA) United States $0.320B 0.00
Bioventus (BVS) United States $0.316B 0.00
Black Diamond Therapeutics (BDTX) United States $0.310B 0.00
Aquestive Therapeutics (AQST) United States $0.306B 0.00
Nektar Therapeutics (NKTR) United States $0.303B 0.00
ESSA Pharma (EPIX) Canada $0.293B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.287B 0.00
Nanobiotix S.A (NBTX) France $0.283B 0.00
Metagenomi (MGX) United States $0.264B 0.00
Akebia Therapeutics (AKBA) United States $0.260B 0.00
Xeris Biopharma Holdings (XERS) United States $0.259B 0.00
Pyxis Oncology (PYXS) United States $0.259B 0.00
Aldeyra Therapeutics (ALDX) United States $0.250B 0.00
Foghorn Therapeutics (FHTX) United States $0.249B 0.00
Adherex Technologies (FENC) United States $0.246B 0.00
Avita Medical (RCEL) United States $0.223B 0.00
Galectin Therapeutics (GALT) United States $0.217B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Eliem Therapeutics (ELYM) United States $0.210B 0.00
Conduit Pharmaceuticals (CDT) United States $0.208B 0.00
Telomir Pharmaceuticals (TELO) United States $0.202B 0.00
Zevra Therapeutics (ZVRA) United States $0.200B 0.00
Century Therapeutics (IPSC) United States $0.197B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.191B 0.00
Acrivon Therapeutics (ACRV) United States $0.186B 0.00
MediWound (MDWD) Israel $0.183B 0.00
Profound Medical (PROF) Canada $0.182B 0.00
Incannex Healthcare (IXHL) Australia $0.169B 0.00
Regulus Therapeutics (RGLS) United States $0.164B 0.00
Prelude Therapeutics (PRLD) United States $0.157B 0.00
Achieve Life Sciences (ACHV) Canada $0.155B 0.00
Cardiol Therapeutics (CRDL) Canada $0.141B 0.00
Elite Pharmaceuticals (ELTP) United States $0.138B 12.91
CytoDyn (CYDY) United States $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.131B 2.76
Karyopharm Therapeutics (KPTI) United States $0.126B 0.00
VAXART, INC (VXRT) United States $0.124B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Citius Pharmaceuticals (CTXR) United States $0.116B 0.00
Relmada Therapeutics (RLMD) United States $0.111B 0.00
GlycoMimetics (GLYC) United States $0.104B 0.00
OptiNose (OPTN) United States $0.103B 0.00
Inotiv (NOTV) United States $0.101B 0.00
PMV Pharmaceuticals (PMVP) United States $0.096B 0.00
ProPhase Labs (PRPH) United States $0.094B 0.00
AlloVir (ALVR) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.091B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.091B 0.00
Aclaris Therapeutics (ACRS) United States $0.090B 0.00
Assertio Holdings (ASRT) United States $0.088B 7.09
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.081B 0.00
Tempest Therapeutics (TPST) United States $0.080B 0.00
Journey Medical (DERM) United States $0.070B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.97
Mural Oncology (MURA) Ireland $0.064B 0.00
Jaguar Animal Health (JAGX) United States $0.062B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.057B 0.00
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Unicycive Therapeutics (UNCY) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
CASI Pharmaceuticals (CASI) China $0.032B 0.00
Surrozen (SRZN) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
DURECT (DRRX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
PolyPid (PYPD) Israel $0.024B 0.00
NRx Pharmaceuticals (NRXP) United States $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.020B 9.47
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Avalo Therapeutics (AVTX) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.34
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.53